Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AAK1 | Q2M2I8 | 6/20 | 0.46 |
| ▸ | BRD4 | O60885 | 1/20 | 0.38 |
| ▸ | ROCK2 | O75116 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | ABL1 | P00519 | 1/20 | 0.36 |
| ▸ | GPR39 | O43194 | 1/20 | 0.36 |
| ▸ | MMP13 | P45452 | 1/20 | 0.36 |
| ▸ | BRAF | P15056 | 1/20 | 0.35 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.35 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.35 |
| ▸ | KCNA5 | P22460 | 1/20 | 0.35 |
| ▸ | TBK1 | Q9UHD2 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17653107 | 0.86 | KDM4E (0.41) | AAK1ROCK2KDM4E | |
| SCHEMBL17653133 | 0.83 | AAK1 (0.42) | AAK1BRD4ABL1BRAFKCNA5 | |
| SCHEMBL17653084 | 0.83 | KDM4E (0.44) | AAK1KDM4E | |
| SCHEMBL17653114 | 0.83 | AAK1 (0.41) | AAK1BRD4KDM4EABL1BRAF | |
| SCHEMBL17653175 | 0.82 | KDM4E (0.43) | AAK1KDM4EMMP13 | |
| SCHEMBL17653150 | 0.81 | AAK1 (0.49) | AAK1KDM4EMMP13 | |
| SCHEMBL17653110 | 0.81 | IMPDH2 (0.46) | AAK1KDM4E | |
| SCHEMBL17653349 | 0.80 | AAK1 (0.45) | AAK1KDM4E | |
| SCHEMBL17653196 | 0.79 | AAK1 (0.39) | AAK1KDM4EMMP13 | |
| SCHEMBL17663485 | 0.77 | AAK1 (0.59) | AAK1ROCK2GPR39 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3200797-A1 | QUINAZOLINE-BASED KINASE INHIBITORS | Bristol-Myers Squibb Company (US) | 2017-08-09 | — | — | EP | disclosed |
| WO-2016053794-A1 | QUINAZOLINE-BASED KINASE INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2016-04-07 | — | — | WO | disclosed |